These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 985646)

  • 1. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn.
    Manchester D; Margolis HS; Sheldon RE
    Am J Obstet Gynecol; 1976 Oct; 126(4):467-9. PubMed ID: 985646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Persistent pulmonary hypertension in the newborn caused by prenatal use of prostaglandin inhibitors, (indomethacin). Report of a case].
    Lozano González CH; Galindo Jiménez P; Pezzotti MA; Lowenberg Favela E
    Ginecol Obstet Mex; 1980 Aug; 48(286):103-10. PubMed ID: 7450523
    [No Abstract]   [Full Text] [Related]  

  • 3. Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe.
    Levin DL; Mills LJ; Parkey M; Garriott J; Campbell W
    J Pediatr; 1979 Apr; 94(4):647-50. PubMed ID: 430314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of aspirin and acetaminophen in pregnancy and in the newborn.
    Rudolph AM
    Arch Intern Med; 1981 Feb; 141(3 Spec No):358-63. PubMed ID: 7469626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal and neonatal effects of indomethacin used as a tocolytic agent.
    Dudley DK; Hardie MJ
    Am J Obstet Gynecol; 1985 Jan; 151(2):181-4. PubMed ID: 3970083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin synthesis inhibition in persistent pulmonary hypertension of the newborn.
    Turner GR; Levin DL
    Clin Perinatol; 1984 Oct; 11(3):581-9. PubMed ID: 6488671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Maternal treatment with indomethacin and severe neonatal pulmonary hypertension (author's transl)].
    Dalens B; Dechelotte P; Gaulme J; Raynaud EJ
    Arch Fr Pediatr; 1981 Apr; 38(4):261-5. PubMed ID: 7294953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome.
    Csaba IF; Sulyok E; Ertl T
    J Pediatr; 1978 Mar; 92(3):484. PubMed ID: 632996
    [No Abstract]   [Full Text] [Related]  

  • 9. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent pulmonary hypertension in a premature newborn after 16 hours of antenatal indomethacin exposure.
    Tarcan A; Gürakan B; Yildirim S; Ozkiraz S; Bilezikçi B
    J Perinat Med; 2004; 32(1):98-9. PubMed ID: 15008397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. A possible mechanism for persistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infant.
    Levin DL; Mills LJ; Weinberg AG
    Circulation; 1979 Aug; 60(2):360-4. PubMed ID: 445754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhibition of prostaglandin synthesis on fetal development, oxygenation, and the fetal circulation.
    Levin DL
    Semin Perinatol; 1980 Jan; 4(1):35-44. PubMed ID: 6992279
    [No Abstract]   [Full Text] [Related]  

  • 13. Indomethacin and fetal ductus arteriosus: complete closure after cessation of prolonged therapeutic course.
    Ben-David Y; Hallak M; Rotschild A; Sorokin Y; Auslender R; Abramovici H
    Fetal Diagn Ther; 1996; 11(5):341-4. PubMed ID: 8894629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preterm parturition. Prostaglandin synthetase inhibitors.
    Niebyl JR
    Semin Perinatol; 1981 Jul; 5(3):274-87. PubMed ID: 6792710
    [No Abstract]   [Full Text] [Related]  

  • 15. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus.
    Moise KJ; Huhta JC; Sharif DS; Ou CN; Kirshon B; Wasserstrum N; Cano L
    N Engl J Med; 1988 Aug; 319(6):327-31. PubMed ID: 3393194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premature onset of labor, neonatal patent ductus arteriosus, and prostaglandin synthetase antagonists--a rat model of a human problem.
    Altshuler G; Krous HF; Altmiller DH; Sharpe GL
    Am J Obstet Gynecol; 1979 Sep; 135(2):261-5. PubMed ID: 112867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of premature labor with indomethacin.
    Niebyl JR; Blake DA; White RD; Kumor KM; Dubin NH; Robinson JC; Egner PG
    Am J Obstet Gynecol; 1980 Apr; 136(8):1014-9. PubMed ID: 7369252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal outcome after indomethacin treatment for preterm labor.
    Niebyl JR; Witter FR
    Am J Obstet Gynecol; 1986 Oct; 155(4):747-9. PubMed ID: 3766630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indomethacin in threatening premature labor. Fetal and neonatal cardiovascular effects].
    Díaz-Calderon O; Velazco-Olivares M; Danglot-Banck C; Gómez-Gomez M; Covarrubias-Villegas R
    Ginecol Obstet Mex; 1992 Dec; 60():326-30. PubMed ID: 1478511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study.
    Eronen M; Pesonen E; Kurki T; Ylikorkala O; Hallman M
    Am J Obstet Gynecol; 1991 Jan; 164(1 Pt 1):141-6. PubMed ID: 1986601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.